Adaptive Phage Therapeutics Overview
Privately-held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections
Latest News
No news articles.
Adaptive Phage Therapeutics Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—Adaptive Phage Therapeutics Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
Adaptive Phage Therapeutics Lifecycle
Adaptive Phage Therapeutics News
0 articlesNo news articles.
Adaptive Phage Therapeutics Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Adaptive Phage Therapeutics Internal
Recent Updates
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-03-07 14:54:26.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-03-07 14:54:48.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-03-07 14:54:48.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-03-07 14:54:48.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-03-07 14:54:48.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-03-07 14:54:48.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-03-07 14:54:27.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-03-07 14:54:27.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 8/100 |
| Missing | funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, logo, description, video or image, funding rounds, news, markets, external profiles, not claimed |
| Creator | Ortal Wein |
| Creator email | ortalw@sncentral.org |
| Last update | 2024-03-07T00:00:00.000Z |
| Created | 2024-03-07T00:00:00.000Z |
| Hidden | Pending approval - External entity (visible: 0) |
| Status detail | Acquired by BiomX on Mar, 2024 |